Jupiter Research Capital (Asia) Ltd’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$172K Buy
+22,374
New +$219K 0.02% 617
2026
Q2
– Sell
-28,712
Closed -$243K – 1018
2026
Q1
$243K Buy
28,712
+15,741
+121% +$150K 0.03% 592
2025
Q4
$157K Buy
+12,971
New +$158K 0.03% 532

Other funds holding OCUL

Jupiter Research Capital (Asia) Ltd's OCUL Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 22,374 shares worth $172K. The stake represents 0.02% of the portfolio and ranks #617 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in OCUL as recently as Q1 2026.

Jupiter Research Capital (Asia) Ltd first reported a position in OCUL in Q4 2025 and has held it in 3 quarters since. The position peaked at $243K in Q1 2026. 253 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 22,374 shares of Ocular Therapeutix worth $172K as of Q3 2026.
  • Ocular Therapeutix was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Ocular Therapeutix made up 0.02% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #617 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 3 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Ocular Therapeutix position peaked at $243K in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.